This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal first-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.
NEOGEN (NEOG) Fortifies Global Position via Megazyme Buyout
by Zacks Equity Research
NEOGEN's (NEOG) buyout of Megazyme is expected to strengthen its Food Safety business worldwide.
Hologic (HOLX) Completes SOMATEX Buyout, Expands Portfolio
by Zacks Equity Research
Hologic (HOLX) to expand biopsy portfolio as well as enhance patient experience via the SOMATEX buyout.
Will Walgreens Boots' (WBA) Retail Arm Be Dull in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) retail pharmacy international sales are likely to remain dull in Q1 on difficult market scenario in the United Kingdom.
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.
Ensign Group (ENSG) on Buyout Spree, Expands in California
by Zacks Equity Research
Ensign Group (ENSG) acquires three skilled nursing facilities in Southern California, which further reinforces its efforts to strengthen nationwide presence.
Zacks.com featured highlights include: Crocs, Sysco, Hologic, Deere & Co and Lennar Corp
by Zacks Equity Research
Zacks.com featured highlights include: Crocs, Sysco, Hologic, Deere & Co and Lennar Corp
5 Top-Ranked Stocks Poised to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
Here's Why You Should Hold on to NuVasive (NUVA) Stock for Now
by Zacks Equity Research
Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently launched products as well as potential in its U.S. Surgical Support business.
Here's Why You Should Hold on to Illumina (ILMN) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.
Integra (IART) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Integra (IART) is optimistic about maintaining a robust product portfolio amid the pandemic-led business disruptions.
T2 Biosystems (TTOO) Jumps: Stock Rises 8.7%
by Zacks Equity Research
T2 Biosystems (TTOO) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
5 Soaring MedTech Stocks to Buy for More Growth in 2021
by Urmimala Biswas
We have selected five MedTech growth stocks with further rooms for improvement in 2021.
5 High Earnings Yield Stocks to Make You Richer in 2021
by Rimmi Singhi
With other things remaining constant, a stock with higher earnings yield has the potential of providing comparatively greater returns. Check out these five high earnings yield picks for a winning portfolio.
Teleflex (TFX) Completes Buyout of Hemostatic Goods Producer
by Zacks Equity Research
Teleflex (TFX) to leverage its strength in enhancing clinical efficacy and patient safety via the recent buyout.
Integra (IART) to Buy ACell, Expand Regenerative Capability
by Zacks Equity Research
Integra (IART) expects to close the ACell acquisition in the first quarter of 2021, subject to fulfilment of closing conditions.
The Zacks Analyst Blog Highlights: FedEx, Lennar, Hologic, Micron and Liberty
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FedEx, Lennar, Hologic, Micron and Liberty
4 MedTech Stocks Up More Than 100% in 2020 With Room to Run
by Urmimala Biswas
We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.
NEOGEN (NEOG) Q2 Earnings and Revenues Fall Shy of Estimates
by Zacks Equity Research
NEOGEN's (NEOG) segmental revenues improve for fiscal second quarter on strong sales of cleaners and disinfectants.
5 Top-Ranked Momentum Stocks for 2021That Have Surged YTD
by Nalak Das
It will be prudent invest in momentum stocks that have surged year to date and sport a top Zacks Rank. These are FDX, HOLX, LEN, LBRDA and MU.
Here's Why You Should Hold onto NEOGEN (NEOG) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about NEOGEN (NEOG) on robust segmental and geographical growth.
Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021
by Zacks Equity Research
Four large-cap MedTech stocks are currently flourishing on the back of several positive developments
Top Ranked Growth Stocks to Buy for December 18th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 18th.
How to Follow the Central Bank Money
by John Blank
Easy Money Drives Stocks. What Works Best?